Home Tags Zaltrap

Tag: Zaltrap

Eye drug drives eye-popping company growth

Regeneron Pharmaceuticals in Greenburgh reported more than doubling revenue in 2012, driven by $838 million in sales of its 1-year-old drug Eylea.

Regeneron Takes Top Spot in Science Magazine Survey

Regeneron Pharmaceuticals Inc., long considered to be the cornerstone of a fast-emerging biotechnology cluster here in the Hudson Valley, was ranked the number one employer in the global biopharmaceutical industry by Science magazine.

Regeneron cancer drug approved

The FDA approved Zaltrap to treat colorectal cancer, but asked for more data on a drug to treat gout.

Zaltrap granted priority review by FDA

Zaltrap, currently in clinical trials after being developed by Regeneron Pharmaceuticals Inc. and Sanofi, has been granted priority review by the FDA.